Seeking Alpha

Aphria up 2% premarket on FQ2 results

|About: Aphria Inc. (APHA)|By: , SA News Editor

Aphria (OTC:APHA) Q2 results (C$): Revenues: 120.6M (+455.8%); Net cannabis revenue: 33.7M.

Kg equivalents sold: 7,062.

Average retail selling price of medical cannabis per gram: 8.16; average selling price of adult-use cannabis per gram: 5.22.

Net loss: (7.9M) (-114.4%); loss/share: (0.03) (-113.6%); non-GAAP EBITDA: 1.9M (-120.0%).

The company received EU GMP compliance confirmation for ARA-Avanti Rx Analytics.

Irwin D. Simon, will officially remove "interim" from his title, effective today. Mr. Simon had been serving as Interim CEO since February 2019.

Fiscal 2020 guidance: Revenue: 575M - 625M (distribution revenue will represent slightly more than half) from 650M - 700M; non-GAAP EBITDA: approx. 35M - 42M from 88M - 95M.

Shares are up 2% premarket.

Try Seeking Alpha PREMIUM for unlimited analysis on APHA